Maraviroc improves liver fibrosis in HIV/hepatitis C co-infected patients
Treatment as prevention: what are the next steps?
Raltegravir combined with Kaletra associated with good preservation of bone density over 96 weeks
Daily aciclovir slows HIV disease progression and reduces viral load
HPTN 052: early treatment reduces serious illness by 40%
Treatment is prevention: HPTN 052 study shows 96% reduction in transmission when HIV-positive partner starts treatment early
Life expectancy for people with HIV in Africa may be comparable to general population if they are on treatment
Doubt remains if HIV therapy increases the risk of fragility fractures
